Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$2.19B |
| 2 |
GE Vernova
GEV
|
+$1.16B |
| 3 |
Meta Platforms (Facebook)
META
|
+$501M |
| 4 |
Palantir
PLTR
|
+$451M |
| 5 |
DoorDash
DASH
|
+$411M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.22B |
| 2 |
Ascendis Pharma A/S
ASND
|
+$866M |
| 3 |
Applovin
APP
|
+$690M |
| 4 |
DAY
Dayforce
DAY
|
+$576M |
| 5 |
Workday
WDAY
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.5% |
| 2 | Healthcare | 20.49% |
| 3 | Industrials | 11.17% |
| 4 | Consumer Discretionary | 9.27% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Criteo
CRTO
$1.03B
| $31.8M | 0.02% |
1,769,644
+77,145
| +5% | +$1.45M |
|
502
Citigroup
C
$222B
| $31.6M | 0.02% |
279,014
-355,173
| -56% | -$40.4M |
|
503
Westlake Corp
WLK
$9.46B
| $31.5M | 0.02% |
269,783
-64,810
| -19% | -$6.28M |
|
504
Novanta
NOVT
$5.04B
| $31.4M | 0.02% |
265,654
-31,544
| -11% | -$4.14M |
|
505
Driven Brands
DRVN
$2.25B
| $31.3M | 0.02% |
2,484,305
+7,126
| +0.3% | +$100K |
|
|
CWAN
506
DELISTED
Clearwater Analytics
CWAN
| $31.2M | 0.01% |
1,318,897
-2,163,796
| -62% | -$51.2M |
|
507
Commercial Metals
CMC
$7.63B
| $31M | 0.01% |
505,209
+14,733
| +3% | +$1.06M |
|
508
Tetra Tech
TTEK
$8.23B
| $31M | 0.01% |
1,029,853
-931,437
| -47% | -$32.9M |
|
509
Sanofi
SNY
$104B
| $30.9M | 0.01% |
642,277
-70,334
| -10% | -$3.28M |
|
510
Boot Barn
BOOT
$4.55B
| $30.9M | 0.01% |
211,066
+43,786
| +26% | +$7.94M |
|
511
Rambus
RMBS
$10.4B
| $30.9M | 0.01% |
358,892
-20,623
| -5% | -$2.06M |
|
512
Forte Biosciences
FBRX
$1.12B
| $30.8M | 0.01% |
1,188,060
-237,725
| -17% | -$6.85M |
|
513
Benitec Biopharma
BNTC
$394M
| $30.7M | 0.01% |
2,876,380
-35,308
| -1% | -$409K |
|
|
SUNB
514
Sunbelt Rentals Holdings
SUNB
$31B
| $30.5M | 0.01% |
+488,181
| New | +$34.3M |
|
515
US Foods
USFD
$21.4B
| $30.5M | 0.01% |
331,032
+231,651
| +233% | +$20.5M |
|
516
Insulet
PODD
$11.3B
| $30.4M | 0.01% |
144,818
+53,714
| +59% | +$13.5M |
|
517
LivaNova
LIVN
$4.3B
| $30M | 0.01% |
471,379
+448,703
| +1,979% | +$28.9M |
|
518
PepsiCo
PEP
$186B
| $29.2M | 0.01% |
188,029
+41,478
| +28% | +$6.46M |
|
519
Constellation Energy
CEG
$98B
| $29.1M | 0.01% |
104,332
+73,957
| +243% | +$22.5M |
|
520
Tenax Therapeutics
TENX
$385M
| $29.1M | 0.01% |
1,815,474
+1,648,808
| +989% | +$22.3M |
|
521
Helios Technologies
HLIO
$2.64B
| $29M | 0.01% |
448,501
-26,481
| -6% | -$1.77M |
|
522
Solid Biosciences
SLDB
$771M
| $28.9M | 0.01% |
+4,010,695
| New | +$25.8M |
|
523
OFG Bancorp
OFG
$2.21B
| $28.8M | 0.01% |
711,933
-12,839
| -2% | -$520K |
|
524
Coinbase
COIN
$41.7B
| $28.8M | 0.01% |
164,751
-384,553
| -70% | -$75.7M |
|
525
Axalta
AXTA
$7.01B
| $28.7M | 0.01% |
1,036,806
+39,385
| +4% | +$1.25M |
|
Similar funds
Janus Henderson Group's Q1 2026 Portfolio in Review
As of Q1 2026, Janus Henderson Group held 2,488 positions worth $209B, down 6.2% from $223B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Janus Henderson Group's Q1 2026 filing shows 82 new, 739 increased, 627 reduced and 81 closed positions. Its largest new stake was Forgent Power Solutions: 7,769,612 shares worth $227M. The largest sale was Microsoft, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2026 buy was Forgent Power Solutions: 7,769,612 shares worth $227M.
- Janus Henderson Group added most to AstraZeneca in Q1 2026, an estimated $2.19B increase.
- Janus Henderson Group's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Ascendis Pharma A/S in Q1 2026, selling an estimated $866M.
- Janus Henderson Group's ten largest holdings make up 30% of its $209B portfolio in Q1 2026.
- Janus Henderson Group opened 82 new positions and closed 81 in Q1 2026.
- Janus Henderson Group's portfolio value fell 6.2% quarter-over-quarter to $209B.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.